GlassScriptPhysician profile
Charles P Ho
NPI 1083690812
$93,432.61
in general payments reported to CMS, 2019-2025
7 companies · $185 in 2025
The $185 reported for 2025 was more than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $61K · 2020: $22K · 2021: $7,923 · 2022: $1,584 · 2023: $485 · 2024: $816 · 2025: $185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $911 · Consulting Fee: $575.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $911.30 |
| Consulting Fee | $575.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $86,473.27 | 2019-2024 | Bone Anchors With Arthroscopic Delivery System |
| Ge Healthcare | $4,000.00 | 2019 | |
| Siemens Medical Solutions USA, INC. | $1,447.69 | 2022-2023 | Magnetom Vida |
| Stryker Corporation | $1,176.49 | 2019-2025 | Iconix, Inspace, Flexible Guide Pin (Stryker Acl Versitomic) |
| Canon Medical Systems USA, INC. | $144.91 | 2019 | |
| Cleerly, INC. | $130.39 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Bard Peripheral Vascular, INC. | $59.86 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Ho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.